{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:15:55Z","timestamp":1761974155484,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16209012","17590305","1920912","22590316"],"award-info":[{"award-number":["16209012","17590305","1920912","22590316"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.humpath.2012.11.008","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T09:18:11Z","timestamp":1360833491000},"page":"1382-1390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes"],"prefix":"10.1016","volume":"44","author":[{"given":"Takaomi","family":"Koga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Ijichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokujiro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuo","family":"Sueishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2012.11.008_bb0005","first-page":"74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"year":"2004","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","key":"10.1016\/j.humpath.2012.11.008_bb0010"},{"key":"10.1016\/j.humpath.2012.11.008_bb0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jnci\/dji112","article-title":"Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer","volume":"97","author":"Cappuzzo","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2012.11.008_bb0020","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2012.11.008_bb0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2012.11.008_bb0030","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2009.22.6993","article-title":"Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK","volume":"27","author":"Shaw","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2012.11.008_bb0035","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/cncr.24181","article-title":"The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS","volume":"115","author":"Wong","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2012.11.008_bb0040","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ijc.25447","article-title":"CHFR hypermethylation and EGFR mutation are mutually exclusive, and exhibit contrastive clinical backgrounds and outcomes in non-small-cell lung cancer","volume":"128","author":"Koga","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2012.11.008_bb0045","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/ijc.23673","article-title":"CHFR expression is preferentially impaired in smoking-related squamous cell carcinoma of the lung, and the diminished expression significantly harms outcomes","volume":"123","author":"Takeshita","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2012.11.008_bb0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/35019108","article-title":"Chfr defines a mitotic stress checkpoint that delays entry into metaphase","volume":"406","author":"Scolnick","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2012.11.008_bb0055","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1073\/pnas.1337066100","article-title":"Epigenetic inactivation of CHFR in human tumors","volume":"100","author":"Toyota","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humpath.2012.11.008_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/carcin\/24.1.47","article-title":"Frequent hypermethylation of the 5\u2032 CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non small cell lung cancer","volume":"24","author":"Corn","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2012.11.008_bb0065","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/carcin\/23.10.1695","article-title":"Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer","volume":"23","author":"Shibata","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2012.11.008_bb0070","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/sj.onc.1205402","article-title":"Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers","volume":"21","author":"Mizuno","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2012.11.008_bb0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng1538","article-title":"Chfr is required for tumor suppression and Aurora A regulation","volume":"37","author":"Yu","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2012.11.008_bb0080","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1158\/0008-5472.CAN-06-4109","article-title":"Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression","volume":"67","author":"Privette","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2012.11.008_bb0085","first-page":"1730","article-title":"Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma","volume":"7","author":"Koga","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2012.11.008_bb0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0215(20010720)95:4<232::AID-IJC1040>3.0.CO;2-5","article-title":"Heterogeneous distribution of P53 immunoreactivity in human lung adenocarcinoma correlates with MDM2 protein expression, rather than with P53 gene mutation","volume":"95","author":"Koga","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2012.11.008_bb0095","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","article-title":"Revisions in the international system for staging lung cancer","volume":"111","author":"Mountain","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.humpath.2012.11.008_bb0100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1016\/j.humpath.2012.11.008_bb0105","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1158\/0008-5472.CAN-07-6158","article-title":"Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer","volume":"68","author":"Choi","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2012.11.008_bb0110","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1158\/0008-5472.CAN-04-2818","article-title":"Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications","volume":"64","author":"Kosaka","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2012.11.008_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ijc.21290","article-title":"Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells","volume":"118","author":"Janmaat","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2012.11.008_bb0120","doi-asserted-by":"crossref","first-page":"7241","DOI":"10.1158\/0008-5472.CAN-04-1905","article-title":"Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255","volume":"64","author":"Tracy","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2012.11.008_bb0125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1096\/fj.05-4034fje","article-title":"Dimerization and the signal transduction pathway of a small in-frame deletion in the epidermal growth factor receptor","volume":"20","author":"Sakai","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.humpath.2012.11.008_bb0130","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-08-0755","article-title":"PIK3CA cooperates with other phosphatidylinositol 3\u2032-kinase pathway mutations to effect oncogenic transformation","volume":"68","author":"Oda","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2012.11.008_bb0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1837","article-title":"Chfr is linked to tumour metastasis through the downregulation of HDAC1","volume":"11","author":"Oh","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.humpath.2012.11.008_bb0140","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/onc.2009.123","article-title":"CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-kappaB","volume":"28","author":"Kashima","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2012.11.008_bb0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00428-008-0590-0","article-title":"Down-regulation of the metastasis suppressor protein KAI1\/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma","volume":"452","author":"Protzel","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2012.11.008_bb0150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/1471-2407-10-437","article-title":"Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma","volume":"10","author":"Yan","year":"2010","journal-title":"BMC Cancer"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712004364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712004364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:33:32Z","timestamp":1758645212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817712004364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0046817712004364"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2012.11.008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2012.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}